Tonic-Clonic Seizures Market - Global Outlook and Forecast 2022-2028

March 2022 | 63 pages | ID: TD81C16E7AD4EN
Market Monitor Global

Abstracts

Epilepsy is a group of neurological disorders characterized by brief, involuntary episodes of vigorous shaking of a part or complete body. The patient may experience loss or disturbance of consciousness and movements along with sensory or psychiatric disturbances. Grand mal seizures or tonic–clonic seizures are a type of generalized seizures, which affect the entire brain and are the most common type of epileptic seizures. Grand mal seizures are caused by neurotransmitter imbalances, which can also be influenced by fatigue, lack of sleep, hypertension, stress, intense lighting, rapid motion, blood sugar level, anxiety, etc. The grand mal seizures consist of two phases, the tonic phase and the clonic phase. The tonic phase involves loss of consciousness and muscle twitching and the phase usually last only for a few seconds. The clonic phase consists of rapid muscle contraction and relaxation resulting in convulsions.

This report contains market size and forecasts of Tonic-Clonic Seizures in Global, including the following market information:

Global Tonic-Clonic Seizures Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tonic-Clonic Seizures market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Barbiturates Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tonic-Clonic Seizures include Pfizer, Johnson & Johnson, UCB Celltech, Abbott Laboratories, GlaxoSmithKline, Novartis, Sanofi, Takeda and Teva Pharmaceutical. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tonic-Clonic Seizures companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tonic-Clonic Seizures Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tonic-Clonic Seizures Market Segment Percentages, by Type, 2021 (%)

• Barbiturates
• Hydantoin
• Phenyltriazine
• Iminostilbenes
• Benzodiazepines
• Aliphatic Carboxylic Acid
• Others

Global Tonic-Clonic Seizures Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tonic-Clonic Seizures Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Clinics
• Academic and Research Centers
• Others

Global Tonic-Clonic Seizures Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tonic-Clonic Seizures Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tonic-Clonic Seizures revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tonic-Clonic Seizures revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Pfizer
• Johnson & Johnson
• UCB Celltech
• Abbott Laboratories
• GlaxoSmithKline
• Novartis
• Sanofi
• Takeda
• Teva Pharmaceutical

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Tonic-Clonic Seizures Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Tonic-Clonic Seizures Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TONIC-CLONIC SEIZURES OVERALL MARKET SIZE

2.1 Global Tonic-Clonic Seizures Market Size: 2021 VS 2028
2.2 Global Tonic-Clonic Seizures Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Tonic-Clonic Seizures Players in Global Market
3.2 Top Global Tonic-Clonic Seizures Companies Ranked by Revenue
3.3 Global Tonic-Clonic Seizures Revenue by Companies
3.4 Top 3 and Top 5 Tonic-Clonic Seizures Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tonic-Clonic Seizures Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tonic-Clonic Seizures Players in Global Market
  3.6.1 List of Global Tier 1 Tonic-Clonic Seizures Companies
  3.6.2 List of Global Tier 2 and Tier 3 Tonic-Clonic Seizures Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Tonic-Clonic Seizures Market Size Markets, 2021 & 2028
  4.1.2 Barbiturates
  4.1.3 Hydantoin
  4.1.4 Phenyltriazine
  4.1.5 Iminostilbenes
  4.1.6 Benzodiazepines
  4.1.7 Aliphatic Carboxylic Acid
  4.1.8 Others
4.2 By Type - Global Tonic-Clonic Seizures Revenue & Forecasts
  4.2.1 By Type - Global Tonic-Clonic Seizures Revenue, 2017-2022
  4.2.2 By Type - Global Tonic-Clonic Seizures Revenue, 2023-2028
  4.2.3 By Type - Global Tonic-Clonic Seizures Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Tonic-Clonic Seizures Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Clinics
  5.1.4 Academic and Research Centers
  5.1.5 Others
5.2 By Application - Global Tonic-Clonic Seizures Revenue & Forecasts
  5.2.1 By Application - Global Tonic-Clonic Seizures Revenue, 2017-2022
  5.2.2 By Application - Global Tonic-Clonic Seizures Revenue, 2023-2028
  5.2.3 By Application - Global Tonic-Clonic Seizures Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Tonic-Clonic Seizures Market Size, 2021 & 2028
6.2 By Region - Global Tonic-Clonic Seizures Revenue & Forecasts
  6.2.1 By Region - Global Tonic-Clonic Seizures Revenue, 2017-2022
  6.2.2 By Region - Global Tonic-Clonic Seizures Revenue, 2023-2028
  6.2.3 By Region - Global Tonic-Clonic Seizures Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Tonic-Clonic Seizures Revenue, 2017-2028
  6.3.2 US Tonic-Clonic Seizures Market Size, 2017-2028
  6.3.3 Canada Tonic-Clonic Seizures Market Size, 2017-2028
  6.3.4 Mexico Tonic-Clonic Seizures Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Tonic-Clonic Seizures Revenue, 2017-2028
  6.4.2 Germany Tonic-Clonic Seizures Market Size, 2017-2028
  6.4.3 France Tonic-Clonic Seizures Market Size, 2017-2028
  6.4.4 U.K. Tonic-Clonic Seizures Market Size, 2017-2028
  6.4.5 Italy Tonic-Clonic Seizures Market Size, 2017-2028
  6.4.6 Russia Tonic-Clonic Seizures Market Size, 2017-2028
  6.4.7 Nordic Countries Tonic-Clonic Seizures Market Size, 2017-2028
  6.4.8 Benelux Tonic-Clonic Seizures Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Tonic-Clonic Seizures Revenue, 2017-2028
  6.5.2 China Tonic-Clonic Seizures Market Size, 2017-2028
  6.5.3 Japan Tonic-Clonic Seizures Market Size, 2017-2028
  6.5.4 South Korea Tonic-Clonic Seizures Market Size, 2017-2028
  6.5.5 Southeast Asia Tonic-Clonic Seizures Market Size, 2017-2028
  6.5.6 India Tonic-Clonic Seizures Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Tonic-Clonic Seizures Revenue, 2017-2028
  6.6.2 Brazil Tonic-Clonic Seizures Market Size, 2017-2028
  6.6.3 Argentina Tonic-Clonic Seizures Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Tonic-Clonic Seizures Revenue, 2017-2028
  6.7.2 Turkey Tonic-Clonic Seizures Market Size, 2017-2028
  6.7.3 Israel Tonic-Clonic Seizures Market Size, 2017-2028
  6.7.4 Saudi Arabia Tonic-Clonic Seizures Market Size, 2017-2028
  6.7.5 UAE Tonic-Clonic Seizures Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Pfizer
  7.1.1 Pfizer Corporate Summary
  7.1.2 Pfizer Business Overview
  7.1.3 Pfizer Tonic-Clonic Seizures Major Product Offerings
  7.1.4 Pfizer Tonic-Clonic Seizures Revenue in Global Market (2017-2022)
  7.1.5 Pfizer Key News
7.2 Johnson & Johnson
  7.2.1 Johnson & Johnson Corporate Summary
  7.2.2 Johnson & Johnson Business Overview
  7.2.3 Johnson & Johnson Tonic-Clonic Seizures Major Product Offerings
  7.2.4 Johnson & Johnson Tonic-Clonic Seizures Revenue in Global Market (2017-2022)
  7.2.5 Johnson & Johnson Key News
7.3 UCB Celltech
  7.3.1 UCB Celltech Corporate Summary
  7.3.2 UCB Celltech Business Overview
  7.3.3 UCB Celltech Tonic-Clonic Seizures Major Product Offerings
  7.3.4 UCB Celltech Tonic-Clonic Seizures Revenue in Global Market (2017-2022)
  7.3.5 UCB Celltech Key News
7.4 Abbott Laboratories
  7.4.1 Abbott Laboratories Corporate Summary
  7.4.2 Abbott Laboratories Business Overview
  7.4.3 Abbott Laboratories Tonic-Clonic Seizures Major Product Offerings
  7.4.4 Abbott Laboratories Tonic-Clonic Seizures Revenue in Global Market (2017-2022)
  7.4.5 Abbott Laboratories Key News
7.5 GlaxoSmithKline
  7.5.1 GlaxoSmithKline Corporate Summary
  7.5.2 GlaxoSmithKline Business Overview
  7.5.3 GlaxoSmithKline Tonic-Clonic Seizures Major Product Offerings
  7.5.4 GlaxoSmithKline Tonic-Clonic Seizures Revenue in Global Market (2017-2022)
  7.5.5 GlaxoSmithKline Key News
7.6 Novartis
  7.6.1 Novartis Corporate Summary
  7.6.2 Novartis Business Overview
  7.6.3 Novartis Tonic-Clonic Seizures Major Product Offerings
  7.6.4 Novartis Tonic-Clonic Seizures Revenue in Global Market (2017-2022)
  7.6.5 Novartis Key News
7.7 Sanofi
  7.7.1 Sanofi Corporate Summary
  7.7.2 Sanofi Business Overview
  7.7.3 Sanofi Tonic-Clonic Seizures Major Product Offerings
  7.7.4 Sanofi Tonic-Clonic Seizures Revenue in Global Market (2017-2022)
  7.7.5 Sanofi Key News
7.8 Takeda
  7.8.1 Takeda Corporate Summary
  7.8.2 Takeda Business Overview
  7.8.3 Takeda Tonic-Clonic Seizures Major Product Offerings
  7.8.4 Takeda Tonic-Clonic Seizures Revenue in Global Market (2017-2022)
  7.8.5 Takeda Key News
7.9 Teva Pharmaceutical
  7.9.1 Teva Pharmaceutical Corporate Summary
  7.9.2 Teva Pharmaceutical Business Overview
  7.9.3 Teva Pharmaceutical Tonic-Clonic Seizures Major Product Offerings
  7.9.4 Teva Pharmaceutical Tonic-Clonic Seizures Revenue in Global Market (2017-2022)
  7.9.5 Teva Pharmaceutical Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Tonic-Clonic Seizures Market Opportunities & Trends in Global Market
Table 2. Tonic-Clonic Seizures Market Drivers in Global Market
Table 3. Tonic-Clonic Seizures Market Restraints in Global Market
Table 4. Key Players of Tonic-Clonic Seizures in Global Market
Table 5. Top Tonic-Clonic Seizures Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tonic-Clonic Seizures Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tonic-Clonic Seizures Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tonic-Clonic Seizures Product Type
Table 9. List of Global Tier 1 Tonic-Clonic Seizures Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tonic-Clonic Seizures Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tonic-Clonic Seizures Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tonic-Clonic Seizures Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tonic-Clonic Seizures Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Tonic-Clonic Seizures Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tonic-Clonic Seizures Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tonic-Clonic Seizures Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Tonic-Clonic Seizures Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tonic-Clonic Seizures Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tonic-Clonic Seizures Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tonic-Clonic Seizures Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tonic-Clonic Seizures Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tonic-Clonic Seizures Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tonic-Clonic Seizures Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tonic-Clonic Seizures Revenue, (US$, Mn), 2023-2028
Table 30. Pfizer Corporate Summary
Table 31. Pfizer Tonic-Clonic Seizures Product Offerings
Table 32. Pfizer Tonic-Clonic Seizures Revenue (US$, Mn), (2017-2022)
Table 33. Johnson & Johnson Corporate Summary
Table 34. Johnson & Johnson Tonic-Clonic Seizures Product Offerings
Table 35. Johnson & Johnson Tonic-Clonic Seizures Revenue (US$, Mn), (2017-2022)
Table 36. UCB Celltech Corporate Summary
Table 37. UCB Celltech Tonic-Clonic Seizures Product Offerings
Table 38. UCB Celltech Tonic-Clonic Seizures Revenue (US$, Mn), (2017-2022)
Table 39. Abbott Laboratories Corporate Summary
Table 40. Abbott Laboratories Tonic-Clonic Seizures Product Offerings
Table 41. Abbott Laboratories Tonic-Clonic Seizures Revenue (US$, Mn), (2017-2022)
Table 42. GlaxoSmithKline Corporate Summary
Table 43. GlaxoSmithKline Tonic-Clonic Seizures Product Offerings
Table 44. GlaxoSmithKline Tonic-Clonic Seizures Revenue (US$, Mn), (2017-2022)
Table 45. Novartis Corporate Summary
Table 46. Novartis Tonic-Clonic Seizures Product Offerings
Table 47. Novartis Tonic-Clonic Seizures Revenue (US$, Mn), (2017-2022)
Table 48. Sanofi Corporate Summary
Table 49. Sanofi Tonic-Clonic Seizures Product Offerings
Table 50. Sanofi Tonic-Clonic Seizures Revenue (US$, Mn), (2017-2022)
Table 51. Takeda Corporate Summary
Table 52. Takeda Tonic-Clonic Seizures Product Offerings
Table 53. Takeda Tonic-Clonic Seizures Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Corporate Summary
Table 55. Teva Pharmaceutical Tonic-Clonic Seizures Product Offerings
Table 56. Teva Pharmaceutical Tonic-Clonic Seizures Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Tonic-Clonic Seizures Segment by Type in 2021
Figure 2. Tonic-Clonic Seizures Segment by Application in 2021
Figure 3. Global Tonic-Clonic Seizures Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tonic-Clonic Seizures Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tonic-Clonic Seizures Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tonic-Clonic Seizures Revenue in 2021
Figure 8. By Type - Global Tonic-Clonic Seizures Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tonic-Clonic Seizures Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tonic-Clonic Seizures Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tonic-Clonic Seizures Revenue Market Share, 2017-2028
Figure 12. US Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tonic-Clonic Seizures Revenue Market Share, 2017-2028
Figure 16. Germany Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 17. France Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tonic-Clonic Seizures Revenue Market Share, 2017-2028
Figure 24. China Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 28. India Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tonic-Clonic Seizures Revenue Market Share, 2017-2028
Figure 30. Brazil Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tonic-Clonic Seizures Revenue Market Share, 2017-2028
Figure 33. Turkey Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tonic-Clonic Seizures Revenue, (US$, Mn), 2017-2028
Figure 37. Pfizer Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Johnson & Johnson Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. UCB Celltech Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Abbott Laboratories Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. GlaxoSmithKline Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Novartis Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Sanofi Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Takeda Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Tonic-Clonic Seizures Revenue Year Over Year Growth (US$, Mn) & (2017-2022)